E-cadherin expression associated to ER+ breast carcinomas (91, 92) dampens trastuzumab-dependent ADCC through its specific interaction with the inhibitory killer cell lectin-like receptor G1 (KLRG1) on NK cells in preclinical in vitro and in vivo models (93, 94). The gene discussed is ESR1; the disease is breast carcinoma.